Leonardo DRS (DRS) is down about 3.1% to $43.39 in Monday trading (March 30, 2026), a move that appears more consistent with profit-taking than a single company-specific headline. The stock rallied sharply after its late-February results and 2026 outlook, and today’s decline looks like a reset as investors digest valuation and near-term catalysts.

DRS’s most recent major catalyst was its February 24, 2026 report for Q4 and full-year 2025, where it posted $3.648 billion of 2025 revenue, $1.15 adjusted diluted EPS for the year, and issued 2026 guidance for revenue of $3.85–$3.95 billion and adjusted diluted EPS of $1.20–$1.26. The company also highlighted a year-end backlog of $8.7 billion and continued capital investment plans, which can affect near-term free-cash-flow optics even when growth is strong. (leonardodrs.com)

Investors are also parsing March insider activity. A March 16, 2026 corporate filing on the company’s investor SEC-filings page and a March 16 analyst-ratings/insider-sales roundup both point to recent insider transactions in early March, which can amplify short-term volatility when the stock is near multi-month highs. While insider sales are not inherently bearish (they can be diversification or scheduled sales), they can be an easy near-term narrative for traders during a down tape. (investors.leonardodrs.com)

The next clean catalyst is the company’s next earnings update (not yet reported as of March 30, 2026), plus any new large contract awards or backlog updates that could change the near-term growth narrative. Traders will also be watching whether DRS holds the post-earnings price zone around the mid-$40s after the February surge. (leonardodrs.com)